Trabectedin EVER Pharma 1 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Pazopanib PharOS 200 mg film-coated tablets, HALAVEN 0.44 mg/ml solution for injection
IT-03
Phase 3 small_molecule active
Quick answer
Trabectedin EVER Pharma 1 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Pazopanib PharOS 200 mg film-coated tablets, HALAVEN 0.44 mg/ml solution for injection for liposarcoma (dedifferentiated, myxoid, round cell or pleomorphic), Leiomyosarcoma (non-uterine), Undifferentiated pleomorphic sarcoma is a Phase 3 program (small_molecule) at INTENSITY THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTENSITY THERAPEUTICS, INC.
- Indication
- liposarcoma (dedifferentiated, myxoid, round cell or pleomorphic), Leiomyosarcoma (non-uterine), Undifferentiated pleomorphic sarcoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active